Founded in 2001, Axxam is a leading drug discovery Contract Research Organization (CRO) to the life sciences industry.
The company has significant expertise across a range of biology-focused discovery services and specialized technologies including: target assessment, assay development, high-throughput screening, compound management, hit identification and hit validation services. Axxam works with both its own, high quality, internally developed compound collections (synthetic and natural) and those provided by clients and partners.
The Company operates from three sites, two in Italy (Milan, Naples) and one in Germany (Constance), and has an extended commercial presence in Europe and the United States.
Axxam employs around 180 people, most of whom have received PhDs in life sciences related disciplines.
The company has significant expertise across a range of biology-focused discovery services and specialized technologies including: target assessment, assay development, high-throughput screening, compound management, hit identification and hit validation services. Axxam works with both its own, high quality, internally developed compound collections (synthetic and natural) and those provided by clients and partners.
The Company operates from three sites, two in Italy (Milan, Naples) and one in Germany (Constance), and has an extended commercial presence in Europe and the United States.
Axxam employs around 180 people, most of whom have received PhDs in life sciences related disciplines.
Location: Germany, Baden-Württemberg, Karlsruhe
Investors 1
| Date | Name | Website |
| - | Keensight ... | keensightc... |
Mentions in press and media 1
| Date | Title | Description |
| 10.10.2024 | Opertech Bio and AXXSense Enter Strategic Cooperation Agreement | Opertech Bio and AXXSense Enter Strategic Cooperation Agreement Partnership Benefits Customers of Both Organizations PHILADELPHIA and MILAN, Oct. 10, 2024 /PRNewswire-PRWeb/ -- Opertech Bio, a leading innovator in taste assessment, and AXXS... |